Colorectal Cancer

Colorectal cancer is ranked number two in the United States in terms of cancer deaths, behind just lung cancer, but often does not get the same attention as other forms of cancer. However, colorectal cancer presents the opportunity to be preventable. That is why Marianne T. Ritchie, MD, of Jefferson Gastroenterology and Hepatology in Philadelphia, started the Blue Lights Campaign to raise awareness and get more people screened.

Patients with cancer may experience more than double the risk for atrial fibrillation compared with the general population.

Automated CT-based algorithms predicted 5-year CV risk and overall survival in otherwise asymptomatic patients with greater efficacy than the Framingham risk score and BMI, according to a study published in The Lancet Digital Health.

The burden of colorectal cancer has shifted considerably toward younger individuals over the past few decades, according to American Cancer Society’s Colorectal Cancer Statistics 2020 report published in CA: A Cancer Journal for Clinicians.

Non-invasive screening with multitarget stool DNA tests had a high positive predictive value for any colorectal neoplasia regardless of a patient’s exposure to previous colonoscopy, according to study results.

Colorectal cancer is one of the most commonly diagnosed cancers in the Untied States, with the American Cancer Society estimating more than 147,000 new cases in 2020. Although the disease becomes more preventable with early detection, many individuals are not up to date on screening.

Healio Gastroenterology and Liver Disease presents the following reports on the most recent research in endoscopy.

In many respects, this year’s report of cancer incidence and mortality from American Cancer Society, Cancer Statistics 2020, tells a familiar story.

Researchers found that young adults with harmful drinking patterns and steatosis have the highest risk for fibrosis. It was the week’s top story in gastroenterology.

Bleeding in the lower gastrointestinal tract increased risk for incident colorectal cancer in patients with atrial fibrillation who were treated with oral anticoagulants, according to a study published in the European Heart Journal.